Knowledge

Across topics and issues, borders and industries, we have the thought leadership you need to stay ahead of changes in the law.

Across topics and issues, borders and industries, we have the thought leadership you need to stay ahead of changes in the law.

Follow us:

Publications

Insights

China to establish pharmaceutical patent linkage and restoration under U.S./China trade deal
Registered Content

As part of the Phase One U.S./China trade agreement signed on Jan 15, 2020, China has agreed to establish pharmaceutical patent linkage and restoration, which, once implemented, would give...

News

China adds 30 drugs to its "urgently needed" list

Faster review periods and waiver of requirement for Chinese clinical trials are intended to encourage marketing applications

Hogan Lovells Publications

California Chamber of Commerce Challenges the Proposition 65 Acrylamide Warning for Foods

A lawsuit filed yesterday by the California Chamber of Commerce challenges the legality of Proposition 65 warnings on foods that contain acrylamide. The Complaint, which named the Attorney...

Published Works

China: Survival of the Fittest or Cheapest? Update Magazine

Senior Associate Xin Tao authored an article titled "China: Survival of the Fittest or Cheapest?" for Update magazine.

Hogan Lovells Publications

FDA Issues Final Guidance on FCN Requirements for FCS in Contact with Infant Formula and Human Milk

We are writing this memo to bring to your attention that the Food and Drug Administration (FDA) recently published a newfinal guidancetitled: “Preparation of Food Contact...

Hogan Lovells Publications

Executive Insights Biosimilars in China: The Next Frontier The WhiteOak Group

Xin Tao co-authored "Executive Insights Biosimilars in China: The Next Frontier" with professionals from IDG Capital and The WhiteOak Group.

Hogan Lovells Publications

Consumer Horizons 2019

News

U.S. Drug Inspections in China: Staying Ahead of FDA Enforcement Trends

China’s pharmaceutical manufacturing industry is amongst the largest, and, from a supply-chain perspective, one of the most important, in the world. One consequence of China’s...

News

Pharma Companies May Benefit from Proposed Patent Law Changes in China; Public Comment Invited

On January 4, China’s National People’s Congress (NPC) released draft amendments to the Chinese Patent Law, proposing expanded and enhanced protections that may provide real...

Loading data